COST EFFECTIVENESS

Health economic evidence supporting the NCM Technology
in the management of chronic wounds
Cost-effectiveness of using PolyHeal® compared with surgery in the management of chronic wounds with exposed bones and/or tendons due to trauma in France, Germany and the UK1.
Guest JF, et al.

Initial treatment with PolyHeal® instead of surgery is expected to lead to a substantial decrease in healthcare costs.

The cost effectiveness of PolyHeal® is expected to increase even more once PolyHeal® Micro is introduced to market at a substantial lower price.

+ More info

Cost-effectiveness of PolyHeal® Micro in treating chronic wounds with exposed bones and tendons and postoperative chronic wounds2.
Guest JF, et al.

Within the model’s limitations, PolyHeal® Micro affords the NHS a cost-effective (dominant) treatment for chronic wounds with Exposed Bones and Tendons arising from trauma, when compared with surgery.

Within the limitations of the model, PolyHeal® Micro is expected to afford the NHS a cost-effective treatment for post-operative chronic wounds.

+ More info

Latest news

COST EFFECTIVENESS

Cost-effectiveness of PolyHeal in treating chronic wounds with exposed bones and tendons and post-traumatic chronic wounds

+ Play video

INITIAL MANAGEMENT WITH POLYHEAL® MICRO INSTEAD OF SURGERY TO TREAT ALL NEW PATIENTS IS EXPECTED TO SAVE IMPORTANT SURGICAL THEATRE TIME:

PolyHeal® treated patients
need 0.2 surgical procedures per wound

Surgically treated patients
need 1.2 surgical procedures per wound

PolyHeal® is expected to provide the public health-care system in France, Germany and the UK a cost-effective treatment for chronic wounds with exposed bones and tendons due to trauma, when compared with surgery
CHRONIC WOUNDS WITH EXPOSED BONES AND TENDONS DUE TO TRAUMA
Initial treatment with PolyHeal® Micro instead of surgery is expected to lead to a 12% cost decrease of £1,334
PolyHeal® Micro affords the NHS a dominant treatment since the incremental cost for each additional patient healed with PolyHeal® Micro was -£31,000

POST OPERATIVE CHRONIC WOUNDS
Using PolyHeal® Micro instead of standard care is expected to lead to a 7% improvement in health gain of 0.027 QALY over 6 months
Long term outcomes of a randomized controlled trial (RCT) with Negatively Charged Microspheres (NCM) technology compared to control3.
Kaufman H, et al.

Long-term safety and efficacy results as well as a potential reduction in wound care and hospitalization burdens.

+ More info

 
 

STATISTICALLY SIGNIFICANT REDUCTION OF 85% IN UNPLANNED HOSPITALIZATIONS IN THE NCM'S GROUP VS. AN INCREASE OF 55% IN THE CONTROL GROUP

Incidence of Hospitalizations for Wound Management
 

STATISTICALLY SIGNIFICANT MEAN REDUCTION OF 25 HOSPITALIZATION DAYS PER PATIENT VS. AN INCREASE OF 0.91 DAYS IN THE CONTROL GROUP

Duration of Hospitalizations for Wound Management

COST EFFECTIVENESS

Health economic evidence supporting the NCM Technology
in the management of chronic wounds
Cost-effectiveness of using PolyHeal® compared with surgery in the management of chronic wounds with exposed bones and/or tendons due to trauma in France, Germany and the UK1.
Guest JF, et al.

Initial treatment with PolyHeal® instead of surgery is expected to lead to a substantial decrease in healthcare costs.

The cost effectiveness of PolyHeal® is expected to increase even more once PolyHeal® Micro is introduced to market at a substantial lower price.

+ More info

INITIAL MANAGEMENT WITH POLYHEAL® MICRO INSTEAD OF SURGERY TO TREAT ALL NEW PATIENTS IS EXPECTED TO SAVE IMPORTANT SURGICAL THEATRE TIME:

PolyHeal® treated patients
need 0.2 surgical procedures per wound

Surgically treated patients
need 1.2 surgical procedures per wound

PolyHeal® is expected to provide the public health-care system in France, Germany and the UK a cost-effective treatment for chronic wounds with exposed bones and tendons due to trauma, when compared with surgery
Cost-effectiveness of PolyHeal® Micro in treating chronic wounds with exposed bones and tendons and postoperative chronic wounds2.
Guest JF, et al.

Within the model’s limitations, PolyHeal® Micro affords the NHS a cost-effective (dominant) treatment for chronic wounds with Exposed Bones and Tendons arising from trauma, when compared with surgery.

Within the limitations of the model, PolyHeal® Micro is expected to afford the NHS a cost-effective treatment for post-operative chronic wounds.

+ More info

CHRONIC WOUNDS WITH EXPOSED BONES AND TENDONS DUE TO TRAUMA
Initial treatment with PolyHeal® Micro instead of surgery is expected to lead to a 12% cost decrease of £1,334
PolyHeal® Micro affords the NHS a dominant treatment since the incremental cost for each additional patient healed with PolyHeal® Micro was -£31,000

POST OPERATIVE CHRONIC WOUNDS
Using PolyHeal® Micro instead of standard care is expected to lead to a 7% improvement in health gain of 0.027 QALY over 6 months
Long term outcomes of a randomized controlled trial (RCT) with Negatively Charged Microspheres (NCM) technology compared to control3.
Kaufman H, et al.

Long-term safety and efficacy results as well as a potential reduction in wound care and hospitalization burdens.

+ More info

STATISTICALLY SIGNIFICANT REDUCTION OF 85% IN UNPLANNED HOSPITALIZATIONS IN THE NCM'S GROUP VS. AN INCREASE OF 55% IN THE CONTROL GROUP

Incidence of Hospitalizations for Wound Management
 

STATISTICALLY SIGNIFICANT MEAN REDUCTION OF 25 HOSPITALIZATION DAYS PER PATIENT VS. AN INCREASE OF 0.91 DAYS IN THE CONTROL GROUP

Duration of Hospitalizations for Wound Management

Latest news

COST EFFECTIVENESS

Cost-effectiveness of PolyHeal in treating chronic wounds with exposed bones and tendons and post-traumatic chronic wounds

+ Play video


1. Guest JF, et al. Cost-effectiveness of using Polyheal compared with surgery in the management of chronic wounds with exposed bones and/or tendons due to trauma in France, Germany and the UK. Int Wound J. 2015 Feb; 12(1):70-82.
Link to publication

2. Guest JF, et al. Cost-effectiveness of PolyHeal® Micro in treating chronic wounds with exposed bones and tendons and post-operative chronic wounds. Symposium Presentation. Presented in European Wound Management Association Conference (EWMA) 2017. Amsterdam.

3. Kaufman H, et al. Long term outcomes of a randomized controlled trial (RCT) with Negatively Charged Microspheres (NCM) technology compared to control (Poster 374). Presented in European Wound Management Association Conference (EWMA) 2013. Copenhagen May 15th-17th, 2013.
Link to publication